Three effective treatments for COVID-19 not (yet) in guidelines

<p>Paul Sax, MD, FIDSA and clinical trialist extraordinaire David Boulware, MD, MPH, FIDSA discuss promising studies of interferon lambda, metformin, and ensitrelvir for COVID-19 -- and why none of them is currently in treatment guidelines.<br/><br/>*This episode was recorded before the Paxlovid EPIC-SR results <a href='https://www.fda.gov/media/166197/download'>were released in an FDA briefing</a>.</p>